MannKind Stock Price - MNKD

1.08
0.00 (0.0%)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
MannKind Corporation MNKD NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.02 1.89% 1.08 1.02 1.08 1.06 1.06 16:02:07
Bid Price Ask Price Spread Spread % News
1.04 1.08 0.04 3.7% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
4,140 1,373,415 $ 1.05 $ 1,439,834 3,115,471 0.80 - 2.15
Last Trade Time Type Quantity Stock Price Currency
19:02:28 28 $ 1.08 USD

MannKind Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 229.28M 212.30M $ -86.98M -0.27 -4.52 207.55M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

MannKind News

Loading Messages....

Latest MNKD Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MNKD Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.001.100.951.041,765,2760.088.0%
1 Month1.291.380.801.082,824,732-0.21-16.28%
3 Months1.251.880.801.383,128,187-0.17-13.6%
6 Months1.241.880.801.342,502,704-0.16-12.9%
1 Year2.002.150.801.312,333,594-0.92-46.0%
3 Years1.526.960.66622.243,351,531-0.44-28.95%
5 Years5.307.320.412.314,071,716-4.22-79.62%

MannKind Description

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.


$
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.